Table 3.
Adverse events.
| Patients without any adverse event | 1036 (97.6%) |
| Patients with adverse events possibly related to the treatmenta | 25 (2.4%) |
| Diarrhea | 12 |
| Abdominal pain | 3 |
| Headache | 3 |
| Nausea | 2 |
| Insomnia | 2 |
| Transient blurred vision | 2 |
| Vomiting | 1 |
| Urticaria | 1 |
| Erythematous and bullous rash | 1 |
| Discontinuation of treatment | 3 (abdominal pain, urticaria, erythematous and bullous rash) |
Some patients reported more than one adverse event.